Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract
Michael Frumovitz, Shannon N. Westin, Gloria Salvo, Abdulrazzak Zarifa, Mingxuan Xu, Timothy A. Yap, Ahnert J. Rodon, Daniel D. Karp, Abdulrahman Abonofal, Amir A. Jazaeri, Aung Naing
Topics & Concepts
MedicinePembrolizumabAsymptomaticInternal medicineAdverse effectClinical endpointGastroenterologyCarcinomaSurgeryOncologyClinical trialCancerImmunotherapyNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesChromatin Remodeling and Cancer